CVR Energy reports Q1 2026 results today with a striking ownership structure dominating the story — Carl Icahn controls 70.8% of the company and bought more than 780,000 shares in February at prices around $21, a cost roughly 60% below where the stock now trades at $34.13.
The February buying spree was significant. Icahn spent roughly $16.4 million across three days — February 20, 23, and 24 — accumulating shares as the stock sat near multi-year lows. Net insider buying over the 90-day window reached approximately $21 million. That's a heavily concentrated bet from the majority shareholder, made at a substantial discount to the current price. The stock has since rallied 9% in the past week and 4.5% on Wednesday alone, in line with refining peers: DK gained 13.7% on the day, VLO rose 4.6%, and MPC added 4%.
The analyst community is conspicuously bearish despite that price recovery. Goldman Sachs carries a Sell rating, most recently formalised on April 10 with a $30 target. Scotiabank, also with an underperform-equivalent rating, raised its target to $28 on April 22 — still well below the current price. Mizuho holds an Underperform with a $32 target. Raymond James moved from Underperform to Market Perform in late March but stopped short of a positive view. The mean analyst price target of $30.50 implies roughly 11% downside from current levels, and the ORTEX analyst return potential reading sits at -6.6%. The Street's collective message is that the recent rally has run ahead of fundamentals.
Short positioning does not tell a particularly crowded story. The borrow market is loose — availability is ample and the cost to borrow sits near 0.48%, well below anything that would suggest squeeze dynamics. Estimated short interest fell roughly 9% over the past week to a level representing a low share of the float, ranking in just the 9th percentile of the universe on short score. The ORTEX short score of 58 is moderate, and utilization at 15% is far below its 52-week high of 35%. Options positioning has shifted decisively toward calls — the put/call ratio hit a fresh 52-week low of 0.29, nearly 1.7 standard deviations below its 20-day average of 0.43. That is the opposite of a defensive setup; options traders have been progressively buying upside exposure as the stock rallied.
The print will test whether CVI's operations can justify an Icahn-driven stock re-rating that has now put the share price materially above every analyst's target on the Street.
See the live data behind this article on ORTEX.
Open CVI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
